Dapagliflozin Clinical Trials
26 recruitingDrug
Phase 311Phase 29Phase 44Phase 13Not Applicable3
Showing 1–20 of 26 trials
Recruiting
Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
AstraZeneca800 enrolled149 locationsNCT07662044
Recruiting
Phase 3
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
AstraZeneca2,000 enrolled272 locationsNCT07662109
Recruiting
Phase 2Phase 3
"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"
Ascites Hepatic
Beni-Suef University52 enrolled1 locationNCT07684326
Recruiting
Phase 2
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
Renal AL Amyloidosis
Barbara Ann Karmanos Cancer Institute20 enrolled1 locationNCT06420167
Recruiting
Phase 2Phase 3
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Nephrotic Syndrome
Mansoura University75 enrolled1 locationNCT07214818
Recruiting
Phase 1
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Pediatric Solid TumorPediatric Brain Tumor
Washington University School of Medicine20 enrolled1 locationNCT05521984
Recruiting
Phase 2
A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
Chronic Kidney Disease With High Proteinuria
AstraZeneca224 enrolled15 locationsNCT06942910
Recruiting
DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
Chronic Kidney Diseases
King's College Hospital NHS Trust44 enrolled1 locationNCT06572215
Recruiting
Not Applicable
Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
End Stage Chronic Renal Failure
Oman Ministry of Health38 enrolled1 locationNCT07491042
Recruiting
Phase 2
SGLT2 Inhibitors in Geographic Atrophy
Geographic AtrophyRetinal diseasesRetinal Degeneration+2 more
Washington University School of Medicine70 enrolled1 locationNCT07174687
Recruiting
Phase 1Phase 2
Dapagliflozin in Depression
Depression
Tanta University60 enrolled1 locationNCT07239011
Recruiting
Phase 4
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Chronic Kidney Disease(CKD)
Peter Rossing125 enrolled4 locationsNCT07239570
Recruiting
Phase 1
Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
Prostate CancerCancer of Prostate
Washington University School of Medicine24 enrolled1 locationNCT04887935
Recruiting
Not Applicable
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Diabetes Mellitus, Type 2Impaired Glucose Tolerance (IGT)Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio700 enrolled1 locationNCT02969798
Recruiting
Phase 4
Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
Heart Failure
Fundación para la Investigación del Hospital Clínico de Valencia31 enrolled1 locationNCT06578520
Recruiting
Phase 2
Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Diabetic Macular EdemaCenter-Involved Diabetic Macular Edema
Alexandria University56 enrolled1 locationNCT06845163
Recruiting
Phase 2Phase 3
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Ventricular DysfunctionDiabetesAcute Coronary Syndrome+1 more
University of Sao Paulo80 enrolled1 locationNCT06286878
Recruiting
Phase 3
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Type 2 Diabetes
The George Institute994 enrolled8 locationsNCT05345327
Recruiting
Phase 3
Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients
Chronic Kidney Failure in Children and Young Adults
University Hospital Goettingen102 enrolled16 locationsNCT05944016
Recruiting
Phase 3
CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Breast CancerHeart Failure
4th Military Clinical Hospital with Polyclinic, Poland188 enrolled3 locationsNCT06304857